Chapter
Chapter 2: THE EVOLUTION OF CARDIAC TROPONIN TESTING
A BRIEF HISTORY OF TROPONIN IMMUNOASSAYS
TECHNOLOGIES FOR TROPONIN IMMUNOASSAYS
ANALYTICAL CONSIDERATIONS
INTERPRETATION OF CARDIAC TROPONIN RESULTS
STANDARDIZATION AND HARMONIZATION
Chapter 3: HOW TO USE HIGH-SENSITIVITY CARDIAC TROPONIN ASSAYS IN EVERYDAY CLINICAL PRACTICE
DETECTION OF CARDIAC TROPONIN IN APPARENTLY PATHOLOGY FREE INDIVIDUALS
EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION
DISEASES WITH POTENTIAL HS-CTN ELEVATIONS OTHER THAN AMI
SUMMARY REGARDING THE USE OF HS-CTN ASSAYS IN EVERYDAY CLINICAL PRACTICE
Chapter 4: ADVANCED ELECTROCHEMICAL STRATEGIES FOR CARDIAC TROPONINS DETECTION
CARDIAC TROPONIN DETECTION IN CLINICAL SAMPLES
CARDIAC TROPONIN I ELECTROCHEMICAL DETECTION
CARDIAC TROPONIN T ELECTROCHEMICAL DETECTION
MULTIPLEXED ELECTROCHEMICAL DETECTION OF CARDIAC TROPONIN BIOMARKERS
Chapter 5: UPDATE ON QUALITY SPECIFICATIONS FOR CARDIAC TROPONIN ASSAYS
2. BIOCHEMICAL AND PATHOPHYSIOLOGY PROGRESS
3. GENERAL RECOMMENDATIONS ON PRE-ANALYTICAL AND ANALYTICAL FACTORS
Chapter 6: CARDIAC TROPONINS IN THE EVALUATIONOF MYOCARDIAL DAMAGE DURING PERCUTANEOUS CORONARY INTERVENTIONS
PERIPROCEDURAL DAMAGE: DEFINITIONS
MONITORING PCI-RELATED MYOCARDIAL DAMAGE: BIOCHEMICAL VS. IMAGING MODALITIES
CORRELATION BETWEEN PERI-PCI DAMAGE AND SURVIVAL
STRATEGIES TO REDUCE PERIPROCEDURAL DAMAGE
Chapter 7: POST-PROCEDURE TROPONIN ELEVATIONS IN ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
Chapter 8: TROPONIN AS A MARKER OF CLINICALLY SIGNIFICANT MYOCARDIAL INJURY IN TRAUMA
TROPONINS AND MYOCARDIAL CONTUSION
LIMITATIONS OF TROPONIN MEASUREMENTS IN TRAUMA
Chapter 9: TROPONIN AND ACUTE STROKE
5. MECHANISMS OF TROPONIN RISE IN ACUTE STROKE
6. TREATMENT IMPLICATIONS
Chapter 10: INCREASED TROPONIN CONCENTRATION IN PRIMARY NON-CARDIAC DISEASES: CAUSES AND PROGNOSTIC SIGNIFICANCE
II. CTN ELEVATION UNRELATED TO ACUTE CORONARY SYNDROME (ACS)
III. ORGAN-SPECIFIC CAUSES AND RELATED PROGNOSTIC SIGNIFICANCE